RFS

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

HM
Huadong MedicineChina - Hangzhou
1 program
1
Icaritin soft capsulesPhase 21 trial
Active Trials
NCT07328828Active Not RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Huadong MedicineIcaritin soft capsules

Clinical Trials (1)

NCT07328828Huadong MedicineIcaritin soft capsules

Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence

Start: Mar 2024Est. completion: Jun 2026
Phase 2Active Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space